Compare MTN & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTN | MMED |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 1996 | 2026 |
| Metric | MTN | MMED |
|---|---|---|
| Price | $150.36 | $16.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $162.58 | $22.56 |
| AVG Volume (30 Days) | 806.6K | ★ 1.1M |
| Earning Date | 06-04-2026 | 06-03-2026 |
| Dividend Yield | ★ 7.27% | N/A |
| EPS Growth | ★ 24.05 | N/A |
| EPS | ★ 9.43 | N/A |
| Revenue | ★ $2,964,347,000.00 | N/A |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $6.42 | $10.00 |
| P/E Ratio | $15.93 | ★ N/A |
| Revenue Growth | ★ 2.74 | N/A |
| 52 Week Low | $118.51 | $10.65 |
| 52 Week High | $166.16 | $17.86 |
| Indicator | MTN | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 65.81 | 65.82 |
| Support Level | $131.42 | $10.68 |
| Resistance Level | $151.85 | N/A |
| Average True Range (ATR) | 5.22 | 0.81 |
| MACD | 0.99 | 0.02 |
| Stochastic Oscillator | 82.17 | 99.57 |
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.